Mesenchymal Stem Cells Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Mesenchymal Stem Cells Market: By Source (Bone Marrow, Peripheral Blood, Lung Tissue, Umbilical Cord Blood, Amniotic Fluids, Adipose Tissues, and Synovial Tissues), By Applications (Injuries, Drug Discovery, Cardiovascular Infraction and Others), By End User (Clinical Research Organizations, Biotechnological Companies, Medical Research Institutes, and Hospitals), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Mesenchymal Stem Cells Market size was valued at USD 2.70 billion in 2021 and is expected to reach USD 6.20 billion by 2028, at a CAGR of 12.6% during the forecast period 2022-2028. Owing to increase in the prevalence of chronic diseases, degenerative, inflammatory, and autoimmune diseases. Scientific advancements and rising number of biotechnological companies across the globe are expected to propel the growth of the market. Additionally, enhancing application of mesenchymal stem cells for the treatment of chronic diseases, bone and cartilage diseases, and autoimmune diseases, the advantages of mesenchymal stem cells such as ease of isolation, high potential of regeneration and immunoregulatory nature and increasing demand for advanced healthcare facilities are expected to enhance the sale of mesenchymal stem cells market. The report on global market gives historical, current, and future market sizes (US$ Mn) on the basis of source, application, end user, and region. This report studies global mesenchymal stem cells market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

Mesenchymal Stem Cells Market

MARKET SUMMARY
-
12.6%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 12.6%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North-America

Mesenchymal Stem Cells Market

  • The global mesenchymal stem cells market report gives comprehensive outlook on mesenchymal stem cells across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global market gives historical, current, and future market sizes (US$ Mn) on the basis of source, application, end user, and region.
  • Key stakeholders of the global mesenchymal stem cells market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global mesenchymal stem cells products.
Key Players
  • Cell Applications
  • Celprogen
  • Cyagen
  • Genlantis
Mesenchymal Stem Cells Market

Drivers And Restraints

Divers: Increased Awareness about Umbilical Stem Cell
Restraints: Expensive Procedures


North-America got significant share

Mesenchymal Stem Cells Market

North America accounted for larger revenue share in global mesenchymal stem cells market with significant CAGR owing to increasing number of research activities and advancements in technologies, availability of skilled personnel and advanced research facilities and presence of leading market players in the region are expected to increase the growth of the market over the forecasted years. Asia Pacific region is expected to grow at a significant growth rate over the forecast years owing to the enhanced healthcare infrastructure, and presence of large patient pool.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Findings of the Report

  • Global market expanding at significant CAGR over 2022 to 2028 owing to rising prevalence of chronic disorders and rising advancements in technology for the development of new products and drugs
  • Based on application, cardiovascular segment of mesenchymal stem cells accounted for larger market revenue share in 2021 and projected to gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global market

Key

Features of the Report

Mesenchymal Stem Cells Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

  • Cell Applications, Inc. (USA)
  • Celprogen, Inc. (USA)
  • Cyagen US Inc. (USA)
  • Genlantis, Inc. (USA)
  • Lonza Group (Switzerland)
  • Mesoblast Limited (Australia)
  • MilliporeSigma (USA)
  • Neuromics (USA)
  • Orthofix International N.V. (Italy)
  • PromoCell GmbH (Germany)

Description

Mesenchymal Stem Cells Market size was valued at USD 2.70 billion in 2021 and is expected to reach USD 6.20 billion by 2028, at a CAGR of 12.6% during the forecast period 2022-2028. Owing to increase in the prevalence of chronic diseases, degenerative, inflammatory, and autoimmune diseases. Scientific advancements and rising number of biotechnological companies across the globe are expected to propel the growth of the market. Additionally, enhancing application of mesenchymal stem cells for the treatment of chronic diseases, bone and cartilage diseases, and autoimmune diseases, the advantages of mesenchymal stem cells such as ease of isolation, high potential of regeneration and immunoregulatory nature and increasing demand for advanced healthcare facilities are expected to enhance the sale of mesenchymal stem cells market. The report on global market gives historical, current, and future market sizes (US$ Mn) on the basis of source, application, end user, and region. This report studies global mesenchymal stem cells market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX